The reduction in the production of DiHETrE through pharmacological sEH inhibition induced a reduction in blood pressure in models of hypertension, reduced vascular smooth muscle cell proliferation, and inhibited inflammatory pain processes3. Here, EPHX2 is linked to Hypertension.